Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients.
Fiche publication
Date publication
mars 2019
Journal
The Journal of investigative dermatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BENSUSSAN Armand
Tous les auteurs :
Bensussan A, Janela B, Thonnart N, Bagot M, Musette P, Ginhoux F, Marie-Cardine A
Lien Pubmed
Mots clés
Antigens, CD, immunology, Apyrase, immunology, Biomarkers, Tumor, blood, Biopsy, Needle, Case-Control Studies, Flow Cytometry, Humans, Immunohistochemistry, Male, Middle Aged, Neoplastic Cells, Circulating, pathology, Prognosis, Reference Values, Sezary Syndrome, immunology, Skin Neoplasms, immunology, T-Lymphocytes, immunology, Tumor Burden, immunology
Référence
J Invest Dermatol. 2019 03;139(3):725-728